Department of Medicine

New treatment for Crohn’s disease

A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.

Melanoma response to immune therapy

Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.

Department of Medicine Mini-Research Retreat is March 12

The Department of Medicine’s Mini-Research Retreat is Saturday, March 12, from 8 a.m. until noon in Light Hall 208.

mother and baby

Study seeks to ease pediatric HIV infection rates in Africa

Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce.

arm with IV line

Study finds health literacy efforts ease readmission rates

Vanderbilt University Medical Center and Brigham and Women’s Hospital in Boston recently collaborated on a study analysis to determine the effect of a tailored, pharmacist-delivered health literacy intervention on unplanned hospital readmission or emergency department visit following discharge.

hands

Grant bolsters rheumatoid arthritis research

C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.

1 75 76 77 78 79 92